Merrifield C Ann
- SEC CIK
- 0001247224
No open-market purchases or sales filed in the past year.
Current role at each company
- LYRA Lyra Therapeutics, Inc.Directoras of May 16, 2025
- NVIV Invivo Therapeutics Holdings Corp.Directoras of Nov 21, 2022
- FLXN Flexion Therapeutics IncDirectoras of Nov 19, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Merrifield C Ann as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
LYRA Lyra Therapeutics, Inc.
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 17, 2022 (view filing) | May 13-16 | 4 days | Merrifield C AnnDirector | PPurchase | +3.83K | $4.83 | +$18.5K | +109.4%7.33K after | 2 lots |
| Jun 13, 2022 (view filing) | Jun 10 | 3 days | Merrifield C AnnDirector | PPurchase | +4.00K | $5.05 | +$20.2K | +54.6%11.3K after |